The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary

Detaylı Bibliyografya
Asıl Yazarlar:	Yusuf, IH, Foot, B, Galloway, J, Ardern-Jones, MR, Watson, S-L, Yelf, C, Burdon, MA, Bishop, PN, Lotery, AJ
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Nature Publishing Group 2018

Benzer Materyaller

The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary
Yazar:: Yusuf, IH, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Joint recommendations for retinal screening in long‐term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018
Yazar:: Yusuf, IH, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
Yazar:: Yusuf, IH, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom
Yazar:: Yusuf, I, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

New recommendations for retinal monitoring in hydroxychloroquine users: Baseline testing is no longer supported
Yazar:: Yusuf, IH, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
Yazar:: Lotery, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Chloroquine, hydroxychloroquine and COVID-19
Yazar:: Erickson, T. B., ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Ophthalmologists' perspective.
Yazar:: Downes, S, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
Yazar:: Yusuf, IH, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
Yazar:: Gbinigie, O, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy
Yazar:: Chandler, L, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
Yazar:: White, NJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Hydroxychloroquine and Chloroquine Toxicity as Reported by Medical Toxicologists to the Toxicology Investigators Consortium (ToxIC) Registry
Yazar:: Griswold, Matthew K., ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Hydroxychloroquine and Chloroquine Toxicity as Reported by Medical Toxicologists to the Toxicology Investigators Consortium (ToxIC) Registry
Yazar:: Griswold, Matthew K., ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine
Yazar:: Whittaker, DG, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Executive Summary
Yazar:: Burns, Daniel R.
Baskı/Yayın Bilgisi: (2012)

Executive Summary
Yazar:: Burns, Daniel R.
Baskı/Yayın Bilgisi: (2012)

Executive Summary
Yazar:: Burns, Daniel R.
Baskı/Yayın Bilgisi: (2012)

Executive Summary
Yazar:: Burns, Daniel R.
Baskı/Yayın Bilgisi: (2011)

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Yazar:: Axfors, C, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Ergonomic improvements in the working environment of Singaporean Ophthalmologists in the outpatient clinics
Yazar:: Lin, Dianxiang.
Baskı/Yayın Bilgisi: (2013)

An audit of the use of hydroxychloroquine in rheumatology clinics
Yazar:: Worth, C, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Hydroxychloroquine retinopathy.
Yazar:: Yusuf, I, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
Yazar:: Schilling, WHK, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Executive summaries of national reports
Yazar:: World Road Congress (21st : 1999 : Kuala Lumpur)
Baskı/Yayın Bilgisi: (1999)

A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom
Yazar:: Yusuf, IY, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Variation in anaesthesia for the laser treatment of retinopathy of prematurity - a survey of ophthalmologists in the UK
Yazar:: Chen, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Variation in anaesthesia for the laser treatment of retinopathy of prematurity--a survey of ophthalmologists in the UK.
Yazar:: Chen, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Royal College recommendations to improve academic anesthesia in the United kingdom: how they compare with United States proposals.
Yazar:: Pandit, J
Baskı/Yayın Bilgisi: (2006)

Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
Yazar:: Schilling, WHK, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Management decisions for cogeneration : executive summary
Yazar:: Radcliffe, Robert R., ve diğerleri
Baskı/Yayın Bilgisi: (2011)

COMPUTERS IN TEACHING INITIATIVE - AN EXECUTIVE SUMMARY
Yazar:: Gershuny, J, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

Computational propaganda worldwide: Executive summary
Yazar:: Woolley, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Hydroxychloroquine retinopathy: an emerging problem.
Yazar:: Latasiewicz, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

EURO-EXPERT: United Kingdom Data Summary
Yazar:: Holden, L, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Novel imaging techniques for hydroxychloroquine retinopathy
Yazar:: Yusuf, I, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Hydroxychloroquine hitting the headlines: Retinal considerations
Yazar:: Downes, SM, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations.
Yazar:: White, N, ve diğerleri
Baskı/Yayın Bilgisi: (1988)

Executive Summary-Characterization Of Reservoir Fluid Flow Properties
Yazar:: Burns, Daniel R., ve diğerleri
Baskı/Yayın Bilgisi: (2012)

COVID-19 Update Report No. 4 (Executive Summary)
Yazar:: Goentzel, Jarrod, ve diğerleri
Baskı/Yayın Bilgisi: (2020)